$8m FY25 Revenue Result Achieved up 86% vs FY24
Released
Released
Announcement PDF
July 3rd, 2025
ASX RELEASE
$8m FY25 Revenue Result Achieved -up 86% vs
FY24; Launches Flavoured Taki Mai Kava Shots
on Amazon USA
3 July 2025, Brisbane: The Calmer Co. International Limited (ASX: CCO), a Consumer
Packaged Goods company focused on kava and other natural products that support
relaxation, aid sleep, and offer an healthier alternative to alcohol, is pleased to announce
that it has concluded FY25 with preliminary unaudited revenue surpassing AU$8 million,
marking a third consecutive year of strong growth across key sales channels.
Building on this momentum, The Calmer Co is also proud to announce the launch of its
new flavoured Taki Mai Kava Shots on Amazon USA, further accelerating its
expansion into the high-potential US market.
Highlights
• FY25 revenue exceeded AU$8 million, representing 86% year-on-year growth
from FY24 (AU$4.3 million), and a 153% increase from FY23 (AU$1.7 million).
• Revenue for FY25 was generated across a diversified mix of channels:
o
Direct-to-Consumer: 39%
o
Retail: 30%
o
Amazon USA: 23%
o
Wholesale: 8%
• Expanded national retail presence with1:
o
Coles: Taki Mai® Kava shots in 797 stores and 150g FijiKava® Instant
Kava in 801 stores.
o
Woolworths: Successful national launch of 50g FijiKava® Instant Kava
into Australia’s largest supermarket chain (1,100+) stores and more
than 35% market share, further strengthening national distribution
and brand leadership.
• Amazon USA subscriptions now account for 28% of total Amazon sales
volume, highlighting strong customer loyalty and repeat purchasing.
• Taki Mai brand share on Amazon increased from 6% in January to 24% in
April 2025.
• Amazon forecasts a 45% increase in kava sales over the next 12 months,
aligning with The Calmer Co’s strategic growth focus in this key market2.
• Strengthened wholesale channel through growth with IMCD and entry into the
US kava bar market via partnership with Leilo, supporting long-term channel
diversification and volume growth.
Flavoured Taki Mai Kava Shots Launch
Following the successful launch of Taki Mai tincture extracts, The Calmer Co has expanded
its US product portfolio with the launch of five new flavoured Taki Mai Kava Shots on
Amazon USA.
Key Details:
•
•
•
Flavours: Coconut, Choc Banana, Guava, Pineapple, Mango
Formats: 6-pack single flavour and 10-pack mixed flavour
Availability: Exclusively on Amazon USA; direct digital channel to follow
These 2.5oz (75ml) ready-to-drink shots are designed to make kava more enjoyable and
accessible for American consumers seeking natural, alcohol-free relaxation alternatives.
The flavoured range supports The Calmer Co’s global growth ambitions and expansion of
its ready-to-drink (RTD) portfolio.
Andy Burger, Head of E-commerce at The Calmer Co, said:
“Flavoured kava shots are an exciting step forward for our US digital strategy. These new
formats give consumers even more ways to enjoy kava. With Amazon subscriptions and
customer retention growing, we’re confident this launch will build strong momentum
through our online channels.”
Zane Yoshida, Founder & CEO of The Calmer Co, said:
“Crossing AU$8 million in revenue for FY25 is a landmark achievement and reflects the
strength of our multichannel strategy and the dedication of our team. Our new flavoured
kava shots deliver on consumer demand for taste, convenience, and functionality as we
continue to scale globally.”
2
Strategic US Expansion
The United States is a consumer market 13x larger than Australia, with a growing and
increasingly mainstream audience for kava. There are now more than 500 kava bars across
the country, reflecting the rising demand for natural, non-alcoholic alternatives in social
and wellness settings.
Amazon’s projected 45% growth in kava sales over the next 12 months highlights the
momentum behind this emerging category. The Calmer Co manages its US logistics
through Noke 3PL, a Houston-based fulfilment centre provider, alongside Fulfilment by
Amazon (FBA). This dual-channel approach enables fast, cost-effective nationwide shipping
while supporting scalable operations and strong product margins.
Product Mix Transformation
This launch is expected to contribute to a rebalancing of the company’s revenue
composition. As of May, ready-to-drink (RTD) formats account for 7.3% of revenue.
With flavoured shots now available alongside tinctures, The Calmer Co expects the RTD
category to experience significant growth in the year ahead.
View Full ASX Release on Investor Hub
ENDS
1
This announcement has been approved for release by the Board of The Calmer Co.
International Limited.
For further information
Investor & Media Relations
Matthew Reede
Dominion Communications
matt@dominion.partners
+61 414 483 054
1
2
Kava is not permitted to be sold in the Northern Territory
OeP, Acosta Group Fiji Kava 2024-2025 Business Review
3
About the Calmer Co.
The Calmer Co. International Limited (ASX:CCO) is a fast-growing beverage business
leveraging a global opportunity in kava and other natural products that replace alcohol
and support relaxation and sleep.
Our products are delivered to consumers globally through e-commerce channels and
blue-chip retail distribution partners, supported by a reliable farm to shelf supply chain.
The product range includes drinking powders, natural and flavoured kava shots,
concentrates and capsules, sold under the brands Fiji Kava, Taki Mai and Danodan
Hempworks in markets including USA, Australia, New Zealand, China and the Pacific
Islands.
Forward Looking Statements
This ASX release includes certain forward-looking statements that are based on
information and assumptions known to date and are subject to various risks and
uncertainties. Actual results, performance or achievements could be significantly different
from those expressed in, or implied by, these forward-looking statements. Such forwardlooking statements are not guarantees of future performance and involve known and
unknown risks, uncertainties and other factors, many of which are beyond the control of
The Calmer Co. These factors may cause actual results to differ materially from those
expressed in the statements contained in this announcement.
4
Share your feedback
Discover